Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Ureteral Access Sheath Deployment During Ureteroscopy
NCT05197088Phase 3Completed
- Sponsor
- Sengkang General Hospital
- Start
- Mar 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin in nephrolithiasis (2 arms), sponsored by Sengkang General Hospital. Primary endpoint: Number of patients with successful insertion of ureteral access sheath to the upper ureter. Started Mar 2022; status: completed.
02
Drugs
tamsulosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT05197088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05197088.